Polpharma Biologics Growth Timeline
Acquisition of Polpharma by Jerzy Starak, a committed and visionary entrepreneur who still controls Polpharma and Polpharma Biologics today.
Polpharma, a leading pharmaceutical company in Poland and the central European region, launches biotech operations.
Biotechnology R&D centre established in Gdańsk.
Bioeq established - joint venture with Atos on the co-development of Ranibizumab.
Acquisition of Bioceros BV, an early stage biotech development company in Utrecht, the Netherlands.
Rapid development of the biotechnology R&D centre in Gdańsk.
Creation of an independent Polpharma Biologics (spin-off from Polpharma). Out-licensing deal for Natalizumab with Sandoz. Out-licensing deal for Ranibizumab with Coherus.
Duchnice manufacturing and development site joins Polpharma Biologics.
2021 Bioeq, a joint venture of Polpharma Biologics Group, enters into an agreement with Teva to commercialize a biosimilar drug to Ranibizumab in Europe and Canada